Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Perrigo Company Stories

2013-07-19 08:26:56

ALLEGAN, Mich., July 19, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received tentative approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) for repaglinide tablets, the generic equivalent to Prandin® Tablets (repaglinide tablets). (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Prandin® tablets (repaglinide tablets), are indicated as an adjunct to diet and exercise...

2013-06-17 08:29:17

- Expands Perrigo's Rx extended topical portfolio to include ophthalmic sterile ointment and solution products with the addition of nine ANDAs ALLEGAN, Mich., June 17, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has signed a definitive agreement to acquire and has completed the acquisition of an ophthalmic sterile ointment and solution product portfolio from Fera Pharmaceuticals, LLC and its affiliates (Fera), a privately-held, Long Island,...

2013-05-29 08:31:09

ALLEGAN, Mich., May 29, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) announced that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for testosterone topical solution, the generic version of Axiron® Topical Solution. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo previously notified Eli Lilly, the owner of the New Drug Application and Acrux DDS PTY Ltd., owners of patents listed in FDA's Orange...

2013-05-29 08:30:44

ALLEGAN, Mich., May 29, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval for the generic version of Sanctura XR®. Perrigo had previously prevailed in litigation at both the district and appellate levels. The product has begun shipping immediately. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Sanctura XR® (Trospium Chloride Extended-release Capsules, 60 mg), is a once-daily medication for the treatment of...

2013-05-23 08:28:08

ALLEGAN, Mich., May 23, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it is transferring the listing of its U.S. traded common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Select Market (NASDAQ). The Company expects to begin trading on the NYSE on June 6, 2013 under its current stock symbol "PRGO", and will continue to trade on NASDAQ until the transfer takes place. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO )...

2013-05-13 12:28:48

ALLEGAN, Mich., May 13, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced it has kicked off a broad industry marketing and communications campaign to raise awareness for, and consumer confidence in, generic over-the-counter (OTC) medications sold at leading retailers - also known as "store brand" OTCs. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Referencing other successful industry branding campaigns like "Got Milk®?" or "Pork: The Other...

2013-05-07 08:30:55

- Fiscal third quarter net sales increased 18% year over year to a record $920 million. ALLEGAN, Mich., May 7, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE: PRGO) today announced results for its third quarter ended March 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) Perrigo's Chairman and CEO Joseph C. Papa commented, "We are very pleased with our performance, as the team delivered all-time record quarterly revenue and adjusted...

2013-05-02 08:38:38

ALLEGAN, Mich., May 2, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on June 18, 2013 to shareholders of record on May 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) From its beginnings as a packager of generic home remedies in 1887, Allegan, Michigan-based Perrigo Company has grown to become a leading global provider of quality, affordable healthcare...

2013-04-23 16:24:38

ALLEGAN, Mich., April, 23, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE:) today announced that it will release financial results for its third quarter fiscal year 2013 on Tuesday, May 7, 2013 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) The conference call will be available live via...

2013-04-01 12:26:10

YARDLEY, Pa., April 1, 2013 /PRNewswire/ -- The sale of privately-held Velcera, Inc. ("Velcera") -- a leading pet health company committed to providing consumers with best-in-class pet health products that contain the same active ingredients as branded veterinary products but at a significantly lower cost -- to Allegan-Mich.-based Perrigo Company (Nasdaq: PRGO; TASE) closed today for approximately $160 million in cash. Velcera and its FidoPharm subsidiary is best known for its flea and tick...